Monoklonaalsed antikehad, immuunosupressandid, teised astmavastased ained süsteemseks kasutamiseks, teised dermatoloogilised preparaadid
Buyer: sihtasutus Põhja-Eesti Regionaalhaigla
- Published
- 15 November 2023
- Submission deadline
- 18 December 2023, 12:00
- Estimated value
- €47,050,000
- Procedure
- Open procedure
- Documents
- 1
- Notice number
- 00694909-2023
- Reference
- 1be4a285-7c40-4185-8e22-68cf8bf3a2ca
- Official source
- Official source
CPV codes
- 33600000Productos farmacéuticos
Description
Hanke nimetuses toodud ravimite ostmine
Lots (37)
| Lot | Description | CPV code | Amount |
|---|---|---|---|
| 1 | Panitumumab | 33600000 Productos farmacéuticos | €300,000 |
| 2 | Gemtuzumabosogamtsiin | 33600000 Productos farmacéuticos | €100,000 |
| 3 | Brentuksimabvedotiin | 33600000 Productos farmacéuticos | €1,000,000 |
| 4 | Pertuzumab | 33600000 Productos farmacéuticos | €1,000,000 |
| 5 | Trastuzumabemtansiin | 33600000 Productos farmacéuticos | €4,000,000 |
| 6 | Obinutuzumab | 33600000 Productos farmacéuticos | €1,000,000 |
| 7 | Nivolumab | 33600000 Productos farmacéuticos | €5,000,000 |
| 8 | Pembrolizumab | 33600000 Productos farmacéuticos | €11,000,000 |
| 9 | Blinatumomab | 33600000 Productos farmacéuticos | €200,000 |
| 10 | Daratumumab | 33600000 Productos farmacéuticos | €1,000,000 |
| 11 | Inotuzumabosogamitsiin | 33600000 Productos farmacéuticos | €300,000 |
| 12 | Durvalumab | 33600000 Productos farmacéuticos | €2,000,000 |
| 13 | Atezolisumab | 33600000 Productos farmacéuticos | €4,500,000 |
| 14 | Ipilimumab | 33600000 Productos farmacéuticos | €1,000,000 |
| 15 | Karfilsomiib | 33600000 Productos farmacéuticos | €700,000 |
| 16 | Iksasomiib | 33600000 Productos farmacéuticos | €300,000 |
| 17 | Pertuzumab + trastuzumab | 33600000 Productos farmacéuticos | €5,000,000 |
| 18 | Küüliku anti-T-lümfotsüütne immuunoglobuliin | 33600000 Productos farmacéuticos | €100,000 |
| 19 | Okrelizumab | 33600000 Productos farmacéuticos | €800,000 |
| 20 | Abatatsept | 33600000 Productos farmacéuticos | €300,000 |
| 21 | Ekulizumab | 33600000 Productos farmacéuticos | €1,000,000 |
| 22 | Fingolimood | 33600000 Productos farmacéuticos | €50,000 |
| 23 | Vedolizumab | 33600000 Productos farmacéuticos | €400,000 |
| 24 | Golimumab | 33600000 Productos farmacéuticos | €700,000 |
| 25 | Anakinra | 33600000 Productos farmacéuticos | €50,000 |
| 26 | Ustekinumab | 33600000 Productos farmacéuticos | €300,000 |
| 27 | Totsilizumab | 33600000 Productos farmacéuticos | €400,000 |
| 28 | Totsilizumab | 33600000 Productos farmacéuticos | €1,000,000 |
| 29 | Sarilumab | 33600000 Productos farmacéuticos | €500,000 |
| 30 | Guselkumab | 33600000 Productos farmacéuticos | €50,000 |
Award criteria
- Price
Official publications
- TED · 00694909-2023 · 15 November 2023
- OJS · 220/2023 · 15 November 2023
Other tenders from sihtasutus Põhja-Eesti Regionaalhaigla
- Ürituste korraldamine
- Reoveepumplate ja rasvapüüdjate puhastustööd
- Oftalmoloogia töökoha seadmed koos hooldusega
- Trauma ja ortopeedia metallosteosünteesi vahendid
- Printerite täisteenusrent
- Immunohematoloogia reaktiivid tütarhaiglatele
- Fluorestsentsmikroskoop
- Trauma ja ortopeedia metallosteosünteesi vahendid
- Kivipurustussüsteem koos hooldusega
- Müügiloata ravimid
Frequently asked questions
- What is the deadline to bid for this tender?
- The submission deadline is 18 December 2023, 12:00. Check the official source, as dates can be modified.
- What is the estimated value of this tender?
- The estimated value published by the buyer is €47,050,000.
- Who is the buyer of this tender?
- The contracting authority is sihtasutus Põhja-Eesti Regionaalhaigla (European Union).
- How can I bid for public tenders in European Union?
- Bids are submitted through the official procurement portal of European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new tenders from European Union matching your business, every day.
Create a free account and receive new tenders from European Union matching your business, every day.